Skip to content

A Clinical Trial of Chuna Needle Therapy in Early and Moderate Knee Osteoarthritis

A Clinical Trial of Sinew Meridian-Based Chuna Needle Therapy in Early and Moderate Knee Osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000577
Enrollment
Unknown
Registered
2026-03-18
Start date
2026-01-22
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Pestle Acupuncture Treatment Group:Pestle Acupuncture Therapy

Sponsors

Shanghai East Hospital, Yangpu District, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Primary diagnosis meets the diagnostic criteria for knee osteoarthritis (KOA), with clinical staging classified as early- to middle-stage KOA of the Yangming Foot Meridian-Tendon type; 2) Age between 40 and 80 years (inclusive); 3) Able to accept either pestle acupuncture or filiform needle acupuncture, and willing to cooperate with investigators to complete clinical scale assessments honestly; 4) Voluntarily participates in this study, signs the informed consent form, and agrees to undergo relevant examinations for differential diagnosis.

Exclusion criteria

Exclusion criteria: 1) Patients who have been taking long-term medications for KOA and are still within the pharmacological effect period without successful washout; 2) Patients who have undergone joint surgery, those with other knee osteoarticular diseases detected during arthroscopy, or those who have received other relevant treatments that may affect the observation of outcome indicators in this study; 3) Patients with large-area skin boils or ulcers in the lower extremities that interfere with pestle acupuncture treatment; 4) Patients with severe dysfunction of the heart, brain, liver, kidney, or lung; 5) Patients with mental illness or coagulation disorders; 6) Patients with a history of opioid analgesic, sedative-hypnotic, or alcohol abuse; 7) Pregnant or lactating women; 8) Patients with poor compliance who cannot meet the follow-up requirements.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index;

Secondary

MeasureTime frame
Visual Analogue Scale;Temperature of the affected knee joint before and after treatment;

Countries

China

Contacts

Public ContactLi Hanmei

Yinhang Community Health Service Center, Yangpu District, Shanghai

dr_hanmeimei@163.com19928469866

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026